Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05413928 · ClinicalTrials.gov registry record · NA
Effect of Meal Composition and Timing Modification on Glucose Metabolism, Body Temperature and Sleep
A NA study of Healthy and Type 2 Diabetes, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT05413928: Recruiting NA study of Healthy and Type 2 Diabetes, sponsored by Stanford University.
NCT05413928 is a NA study of Healthy and Type 2 Diabetes that is actively recruiting participants, run by Stanford University. The registered enrollment target is 75 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05413928, a NA study of Healthy and Type 2 Diabetes, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of our study is to understand the impact of different meal timing alterations on blood sugars, metabolism, microbiome and sleep physiology in people with prediabetes and diabetes; and to study the temperature/heart rate response to different meals in different people.
Primary Outcome
Change in glycemic control measured from baseline through all phases of study. Glycemic control is derived from continuous glucose monitor (CGM) data and expressed in milligrams/deciliter
Conditions Studied
Interventions
- BEHAVIORAL Time Restrictive Eating- late
- BEHAVIORAL Time Restrictive Eating- early
- BEHAVIORAL Time Restrictive Eating- early with early caloric intake
- OTHER Macronutrient-controlled meals
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT05413928 shows while recruiting
NCT05413928 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower).
The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 4 interventions - of which Time Restrictive Eating- late is the first listed.
NCT05413928 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05413928 about?
NCT05413928 is a clinical study titled "Effect of Meal Composition and Timing Modification on Glucose Metabolism, Body Temperature and Sleep". The purpose of our study is to understand the impact of different meal timing alterations on blood sugars, metabolism, microbiome and sleep physiology in people with prediabetes and diabetes; and to study the temperature/heart rate response to different meals in different people.
What is the current status of trial NCT05413928?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2023-02-01. Estimated completion is 2025-12.
What conditions does trial NCT05413928 study?
This clinical trial studies the following conditions: Healthy, Type 2 Diabetes, PreDiabetes.
What interventions are being tested in trial NCT05413928?
The interventions under investigation include: Time Restrictive Eating- late (BEHAVIORAL), Time Restrictive Eating- early (BEHAVIORAL), Time Restrictive Eating- early with early caloric intake (BEHAVIORAL), Macronutrient-controlled meals (OTHER).
Who is sponsoring clinical trial NCT05413928?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05413928 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05413928's enrollment target sits among peer trials
75 300th of 1090 higher than 781 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI